ABLE: Abilify in Bipolar Disorder for Long-term Effectiveness

Summary

To compare combination treatment of aripiprazole plus valproate versus valproate alone in the prevention of relapse in bipolar I disorder patients with symptomatic remission after 5-6 weeks open-label acute treatment with aripiprazole plus valproate for manic or mixed episode, with or without psychotic features.

Timeline

Start

2007-10

Primary completion

2011-11

Completion

2012-11

Drugs

Indications